IndraLab

Statements



reach
"USP22 downregulation inhibited OS cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in vitro."

reach
"In colon cancer, USP22 was reported to attenuate the invasion capacity of colon cancer cells by inhibiting the STAT3 and MMP9 signaling pathway."

reach
"Downregulation of USP22 inhibited OS cell proliferation, invasion, and EMT in vitro."

reach
"Downregulation of USP22 inhibited OS cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in vitro."

reach
"Downregulation of USP22 Inhibited OS Cell Proliferation and Invasion In Vitro."

reach
"In conclusion, USP22 attenuated the invasion capacity of colon cancer cells by inhibiting the STAT3 and MMP9 signaling pathway."

reach
"The results of in vitro and in vivo studies confirmed USP22 depletion reduced the growth and invasion of ATC cells by regulating the expression and activation of a series of pro tumorigenesis molecules."

reach
"We also suggested that downregulation of USP22 inhibited OS cell proliferation and invasion in vitro."

reach
"Downregulation of USP22 reduces in vitro cancer cell proliferation, survival, migration, and invasion, and decreases in vivo tumor growth and metastasis [6, 10–13]."

reach
"USP22 depletion could significantly inhibit the proliferation and invasion, and promote the apoptosis of ATC cells in vitro."

reach
"The assay results showed that USP22 downregulation significantly inhibited the proliferation (XREF_FIG) and invasion (XREF_FIG) of U2OS and MG-63 cells."